COMPASS Pathways Stock Discussion

$COMPASS Pathways(CMPS.US)$
NEWS
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

$COMPASS Pathways(CMPS.US)$
NEWS
Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

Gainers:
• $Genco Shipping & Trading(GNK.US)$ +4.7% (positive Barrons article)
• $NextDecade(NEXT.US)$ +4.7% (files for 4618226 share common stock offering by selling shareholder)
• $COMPASS Pathways(CMPS.US)$ +4.7% (COMPASS Pathways presents largest ever study of psilocybin therapy at American Psychiatric Association annual meeting)
• $Canoo(GOEV.US)$ +3.5% (files for 48043111 share common stock offering by selling shareholder)
• $American Axle & Mfg(AXL.US)$ +3.7% (pr...

$ATAI Life Sciences(ATAI.US)$
$Cybin(CYBN.US)$ $Enveric Biosciences(ENVB.US)$ $Mind Medicine(MNMD.US)$ $Seelos Therapeutics(SEEL.US)$ $COMPASS Pathways(CMPS.US)$ $ADVISORSHARES PSYCHEDELICS ETF(PSIL.US)$ building up short positions. The whole sector has taken a huge smack regardless of the fda approvels, Cybin having a clinic in New York. Envb having its Psy-ai. Seelos is up big without any indication of why. Mind med is down, started more studies on mdma and lsd. Get ready and load up. Things are looking strange.

$COMPASS Pathways(CMPS.US)$ holy sh**, luckily I put a stop profit at 57 and it got triggered pre market. #my1stSwingtrade

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.
Since early 2020, the industry for medicinal psychedelic drugs received an extraordinary injection of capital, launching several companies in major exchanges like the NYSE and the Nasdaq, some of which now have valuations of over $1 billion.
Psychedelics Companies Listed On The Nasdaq And NYSE
Atai Life Sciences ( $ATAI Life Sciences(ATAI.US)$ )
Compass Pathways ( $COMPASS Pathways(CMPS.US)$ )
MindMed ( $Mind Medicine(MNMD.US)$ )
Field Trip Health, Inc. ( $FIELD TRIP HEALTH LTD(FTRP.US)$ )
Seelos Therapeutics ( $Seelos Therapeutics(SEEL.US)$
Enveric Biosciences ( $Enveric Biosciences(ENVB.US)$ )
Pasithea Therapeutics Corp. ( $Pasithea Therapeutics(KTTA.US)$ )
GH Research ( $Coherus BioSciences(CHRS.US)$ )
Cybin Corp ( $Cybin(CYBN.US)$ )

$COMPASS Pathways(CMPS.US)$  ?
MMEDF
CLABF
LKYSF
TWGL
SHRMF
PSYCHEDELIC . MENTAL HEALTH. TREATMENT?
NONE BELIEVEFS STEP FAR BACK.

$COMPASS Pathways(CMPS.US)$ caught me off guard. bought 30 & now 14% up. something to do with its lead product by end of d year??